NL7115017A - - Google Patents

Info

Publication number
NL7115017A
NL7115017A NL7115017A NL7115017A NL7115017A NL 7115017 A NL7115017 A NL 7115017A NL 7115017 A NL7115017 A NL 7115017A NL 7115017 A NL7115017 A NL 7115017A NL 7115017 A NL7115017 A NL 7115017A
Authority
NL
Netherlands
Application number
NL7115017A
Other versions
NL155016B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7115017A publication Critical patent/NL7115017A/xx
Publication of NL155016B publication Critical patent/NL155016B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL717115017A 1970-11-12 1971-11-01 Werkwijze voor het bereiden van 6-methyl-8-carbonzuur-10-alkoxyergolinederivaten door invoering van de 10-alkoxygroep in een verbinding die zo'n groep niet draagt. NL155016B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT5466070 1970-11-12

Publications (2)

Publication Number Publication Date
NL7115017A true NL7115017A (fr) 1972-05-16
NL155016B NL155016B (nl) 1977-11-15

Family

ID=11287460

Family Applications (1)

Application Number Title Priority Date Filing Date
NL717115017A NL155016B (nl) 1970-11-12 1971-11-01 Werkwijze voor het bereiden van 6-methyl-8-carbonzuur-10-alkoxyergolinederivaten door invoering van de 10-alkoxygroep in een verbinding die zo'n groep niet draagt.

Country Status (20)

Country Link
US (1) US3814765A (fr)
JP (1) JPS5344478B1 (fr)
AT (1) AT310953B (fr)
AU (1) AU466630B2 (fr)
BE (1) BE775145A (fr)
CA (1) CA926864A (fr)
CH (1) CH561721A5 (fr)
CS (1) CS165363B2 (fr)
DE (1) DE2155578C3 (fr)
DK (1) DK140842B (fr)
FR (1) FR2114476A5 (fr)
GB (1) GB1315439A (fr)
HU (1) HU164041B (fr)
IE (1) IE35794B1 (fr)
IL (1) IL38096A (fr)
NL (1) NL155016B (fr)
NO (1) NO128533B (fr)
SE (1) SE385707B (fr)
SU (1) SU406355A3 (fr)
ZA (1) ZA717541B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001242A (en) * 1974-08-02 1977-01-04 Eli Lilly And Company D-6-methyl-8-formyl-10α-alkoxy-8-ergolene
US3929796A (en) * 1974-08-02 1975-12-30 Lilly Co Eli Synthesis of penniclavine and elymoclavine
US3923812A (en) * 1974-08-02 1975-12-02 Lilly Co Eli Synthesis of elymoclavine
US4054567A (en) * 1975-08-11 1977-10-18 Eli Lilly And Company 6-Methyl-8β-hydroxymethyl-8-γ-substituted-9-ergolene compounds
US4082753A (en) * 1976-02-17 1978-04-04 Eli Lilly And Company Penniclavine acetonide
WO2011079313A1 (fr) * 2009-12-23 2011-06-30 Map Pharmaceuticals, Inc. Analogues d'ergoline
US8604035B2 (en) 2011-06-23 2013-12-10 Map Pharmaceuticals, Inc. Fluoroergoline analogs
WO2013095707A1 (fr) 2011-12-19 2013-06-27 Map Pharmaceuticals, Inc. Nouveaux dérivés d'iso-ergoline
EP2793583A4 (fr) 2011-12-21 2015-08-12 Map Pharmaceuticals Inc Nouveaux composés neuromodulateurs
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives

Also Published As

Publication number Publication date
NL155016B (nl) 1977-11-15
DE2155578A1 (de) 1972-05-18
SU406355A3 (fr) 1973-11-05
SE385707B (sv) 1976-07-19
DK140842B (da) 1979-11-26
CH561721A5 (fr) 1975-05-15
FR2114476A5 (fr) 1972-06-30
JPS5344478B1 (fr) 1978-11-29
ZA717541B (en) 1972-08-30
IE35794B1 (en) 1976-05-26
CA926864A (en) 1973-05-22
US3814765A (en) 1974-06-04
DE2155578C3 (de) 1979-01-04
BE775145A (fr) 1972-05-10
AU466630B2 (en) 1975-11-06
IL38096A (en) 1976-02-29
AT310953B (de) 1973-10-25
NO128533B (fr) 1973-12-03
IE35794L (en) 1972-05-12
DE2155578B2 (de) 1978-05-03
CS165363B2 (fr) 1975-12-22
AU3519871A (en) 1973-05-10
HU164041B (fr) 1973-12-28
IL38096A0 (en) 1972-01-27
DK140842C (fr) 1980-05-05
GB1315439A (en) 1973-05-02

Similar Documents

Publication Publication Date Title
SU406355A3 (fr)
AU1146470A (fr)
AU2044470A (fr)
AU2017870A (fr)
AU1716970A (fr)
AU2085370A (fr)
AU442343B2 (fr)
AU1969370A (fr)
AU1943370A (fr)
AU2130770A (fr)
AU1832970A (fr)
AU1841070A (fr)
AU1872870A (fr)
AU1879170A (fr)
AU1881070A (fr)
AU2131570A (fr)
AU1918570A (fr)
AU1974970A (fr)
AU2119370A (fr)
AU2115870A (fr)
AU2061170A (fr)
AU2112570A (fr)
AU2130570A (fr)
AU1789870A (fr)
AU2144270A (fr)

Legal Events

Date Code Title Description
VJC Lapsed due to non-payment of the due maintenance fee for the patent or patent application
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: FARMACEUTICI